Tratamiento de las heridas antisepticos cambiando ideas

14. Yasuda T, Yoshimura S, Katsuno Y, Takada
H, Ito M, Takahashi M et al. Comparison
of bactericidal activities of various
disinfectants against methicillin-sensitive
Staphylococcus aureus and methicillinresistant
Staphylococcus aureus. Postgrad.
Med.J. 1993;69 Suppl 3:S66-S69.
15. Kampf G, Jarosch R, Ruden H. Limited
effectiveness of chlorhexidine based hand
disinfectants against methicillin-resistant
Staphylococcus aureus (MRSA).
J.Hosp.Infect. 1998;38:297-303.
16. Bennett LL, Rosenblum RS, Perlov C,
Davidson JM, Barton RM, Nanney LB. An in
vivo comparison of topical agents on wound
repair. Plast.Reconstr.Surg 2001;108:675-87.
17. Kuniyuki S,.Oonishi H. Chemical burn from
acetic acid with deep ulceration.
Contact Dermatitis 1997;36:169-70.
18. van Saene JJ, Veringa SI, van Saene HK,
Verhoef J, Lerk CF. Effect of chlorhexidine
and acetic acid on phagocytosis by
polymorphonuclear leucocytes.
Eur.J Clin Microbiol. 1985;4:493-7.
19. Doughty D. A rational approach to the use
of topical antiseptics. J Wound.Ostomy.
Continence.Nurs. 1994;21:224-31.
20. Martin L., Vaillant L. Thérapeutique
dermatologique. Paris: Médecine-Sciences
Flammarion, 2001.
21. Gordon J. Clinical significance of methicillinsensitive
and methicillin-resistant
Staphylococcus aureus in UK hospitals and
the relevance of povidone-iodine in their
control. Postgrad.Med J 1993;69
Suppl 3:S106-S116.
22. Mycock G. Methicillin/antiseptic-resistant
Staphylococcus aureus.
Lancet 1985;2:949-50.
23. Lacey RW,.Catto A. Action of povidoneiodine
against methicillin-sensitive and
-resistant cultures of Staphylococcus aureus.
Postgrad.Med.J. 1993;69 Suppl 3:S78-S83.
24. Giacometti A, Cirioni O, Greganti G, Fineo
A, Ghiselli R, Del Prete MS et al. Antiseptic
compounds still active against bacterial
strains isolated from surgical wound
infections despite increasing antibiotic
resistance. Eur.J.Clin.Microbiol.Infect.Dis.
2002;21:553-6.
25. Russell AD. Introduction of biocides
into clinical practice and the impact
on antibiotic-resistant bacteria. J.Appl.
Microbiol. 2002;92 Suppl:121S-35S.
26. Schweizer HP. Triclosan: a widely used
biocide and its link to antibiotics. FEMS
Microbiol.Lett. 2001;202:1-7.
27. Russell AD. Plasmids and bacterial resistance
to biocides.
J.Appl.Microbiol. 1997;82:155-65.
28. Ayliffe GAJ, Buckles A, Casewell MW,
Cookson B, Cox AR, French GL et al. Revised
guidelines for the control of epidemic
methicillin-resistant Staphylococcus aureus
infection in hospitals.
J.Hosp.Infect. 1998;39:253-90.
29. Gales AC, Andrade SS, Sader HS, Jones RN.
Activity of mupirocin and 14 additional
antibiotics against staphylococci isolated
from Latin American hospitals: report from
the SENTRY antimicrobial surveillance
program. J Chemother. 2004;16:323-8.
30. Gosbell IB. Methicillin-resistant
Staphylococcus aureus: impact on
dermatology practice.
Am.J Clin Dermatol. 2004;5:239-59.
31. Kresken M, Hafner D, Schmitz FJ, Wichelhaus
TA. Prevalence of mupirocin resistance in
clinical isolates of Staphylococcus aureus
and Staphylococcus epidermidis: results of
the Antimicrobial Resistance Surveillance
Study of the Paul-Ehrlich-Society for
Chemotherapy, 2001.
Int.J Antimicrob.Agents 2004;23:577-81.
32. Berns JS. Infection with antimicrobialresistant
microorganisms in dialysis patients.
Semin.Dial. 2003;16:30-7.
68
Bibliografía